Generation J

LAUNCHING IN SUMMER 2019

Welcome to Generation J

The very first generation with a treatment available:
JYNARQUE® (tolvaptan)

JYNARQUE is proven to slow kidney function decline in adults who are at risk for rapidly progressing ADPKD.

This generation is changing what it means to live
with ADPKD by taking control of their health,
changing the course of their disease, and continuing
to persevere and explore what's possible.

This is a new generation. This is Generation J.

Be part of the Generation J community by signing
up for updates here.

JYNARQUE is proven to slow kidney function decline in adults who are at risk for rapidly progressing ADPKD.
ADPKD=autosomal dominant polycystic kidney disease.